Late last year, Pat Hannon started waking up in the middle of the night with an excruciating itching sensation on her legs.

This week's round-up of pharma licensing deals features alliances involving Tenaya Therapeutics, Sino Bio, Antengene, and A2A ...

So welcome to our second IR went in 2026, focusing this time on the Phase III ALLEGORY results for Gazyva in SLE, which just got presented last Friday at SLEuro. Today's call is scheduled for 60 ...

Explore how proteomics enables personalized medicine by improving patient stratification, treatment response, and diagnostics ...

Company affirms execution milestones, subscription activation roadmap, and long-term infrastructure vision remain unchanged despite market volatility HOUSTON, TEXAS / ACCESS Newswire / March 9, 2026 / ...

Explore how clinical multi-omics integration drives systems medicine, detailing data fusion methodologies and lab ...

Eli Lilly operates in the healthcare sector as a global pharmaceutical manufacturer with commercial medicines and a broad research portfolio across immunology, oncology, and metabolic health. Eli ...

The human eye is often described metaphorically as the "window to the soul," but in clinical medicine, it is more accurately viewed as a non-invasive window into the human body's circulatory and ...

Research ; Camilla Jandus: "Our immune defences are still far from having revealed all their secrets" Freshly promoted to Associate Professor in the Department of Pathology and Im ...

Dr. Carolyn Mukai, ND, Dr. Lynn Klassen, ND, Dr. Ece Toprak, ND Expanding recognition of infection-triggered ...

A “living drug” was developed as a cancer treatment. Now it is showing promise for conditions, such as lupus and multiple sclerosis, that have long been considered incurable.

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...